With the aim of helping more cancer patients and better disseminating new medical technology, St. Stamford Modern Cancer Hospital and the Philippine Chinese Press Club, Manila Chinatown Charity Foundation and China Boai Charity Foundation, jointly held a new technology conference on CAR-T Therapy titled “NEW TREATMENT, NEW HOPE, NEW LIFE” in Manila on Oct. 19th.
Director Li Xiaoshi
On the conference, Director Li Xiaoshi, a leading expert in the field of oncology who has more than 40 years of clinical experience in treating cancer, give a detailed explanation of CAR-T Therapy. As a breakthrough therapy technology, CAR-T (Chimeric Antigen Receptor T-Cell ) Therapy is the “fifth pillar” of cancer treatment after surgery, chemotherapy, radiotherapy and targeted therapy. It has been recognized by American Science magazine as leader of top 10 scientific breakthroughs of 2013. CAR-T (Chimeric Antigen Receptor T-Cell Therapy) is nowadays the most advanced biological treatment technology and the first gene therapy that has been approved by America FDA.
The theory of CAR-T is to use the patient's own immune cells to clear cancer cells. Through genetic engineering technology, an element that recognizes specific cancer cells will be added to T cells isolated from the patient, rendering T cells to grow an artificial receptor called Chimeric Antigen Receptor (CAR), that would track and kill cancer cells; Millions of copies of these engineered cells are grown in laboratory and given back to the patient intra-veinously.
MR. Tu Xiaoming, the general manager of St. Stamford Modern Cancer Hospital Guangzhou, also attended the conference and gave a speech:“Since our foundation, we have always kept a good medical cooperation. During the past years, we have helped numerous Filipino cancer patients with our advanced minimally invasive therapies. Recently, we introduced a new therapy which is effective in treating lymphoma and leukemia, and can hardly wait to share to you. In the coming future, we will keep enhancing the Philippine-China connection and cooperation in the medical field and make a joint effort to help more cancer patients!”
This new technology conference not only promotes the medical cooperation between both sides, but also brings new hope for patients with lymphoma or leukemia!
*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.